- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,071GBP
Balsalazide is a medication used to treat mild to moderate ulcerative colitis, a type of inflammatory bowel disease. It is a prodrug of mesalamine, which is thought to reduce inflammation in the gastrointestinal tract. Balsalazide is typically taken orally in the form of a capsule or tablet. It is usually taken three times a day with meals. Common side effects include nausea, vomiting, and abdominal pain.
Balsalazide is one of several medications used to treat gastrointestinal diseases. Other medications used to treat ulcerative colitis include aminosalicylates, corticosteroids, immunomodulators, and biologics. Balsalazide is generally considered to be a safe and effective treatment for mild to moderate ulcerative colitis.
Several companies produce and market balsalazide, including AstraZeneca, Merck, and Pfizer. Other companies that produce and market balsalazide include Sandoz, Teva Pharmaceuticals, and Mylan. Show Less Read more